Clinical trial
Nonalcoholic Fatty Liver Disease: Crosstalk Between Genetic Predisposition and Epigenetic Lysosomal Acid Lipase Activity Reduction in Blood, Plasma and Platelets
NCT05419765 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nonalcoholic Fatty Liver Disease: Crosstalk Between Genetic Predisposition and Epigenetic Lysosomal Acid Lipase Activity Reduction in Blood, Plasma and Platelets
- Lead sponsor
- University of Roma La Sapienza
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2022
- Completion date
- March 31, 2023
- Enrollment
- 316 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.